ADCY5 anticorps (AA 584-719) (FITC)

N° du produit ABIN7143332

Détail du produit anti-ADCY5 anticorps (FITC)

Antigène: ADCY5 (Adenylate Cyclase 5 (ADCY5))

Épitope: AA 584-719

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ADCY5 est conjugé à/à la FITC

Application: Veuillez nous consulter SVP

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Adenylate cyclase type 5 protein (584-719AA)

Isotype: IgG

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur ADCY5

Antigène: ADCY5 (Adenylate Cyclase 5 (ADCY5))

Autre désignation: ADCY5 (ADCY5 Produits)

Synonymes: anticorps AC5, anticorps ADCY5, anticorps si:dkeyp-60a7.2, anticorps FDFM, anticorps AW121902, anticorps Ac5, anticorps RUT, anticorps adenylate cyclase 5, anticorps ADCY5, anticorps adcy5, anticorps Adcy5

Sujet:

Background: Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling (PubMed:15385642, PubMed:26206488, PubMed:24700542). Mediates signaling downstream of ADRB1 (PubMed:24700542). Regulates the increase of free cytosolic Ca(2+) in response to increased blood glucose levels and contributes to the regulation of Ca(2+)-dependent insulin secretion (PubMed:24740569).

Aliases: AC 5 antibody, AC5 antibody, ADCY 5 antibody, Adcy5 antibody, ADCY5_HUMAN antibody, Adenylate cyclase type 5 antibody, Adenylate cyclase type V antibody, Adenylyl cyclase 5 antibody, ATP pyrophosphate lyase 5 antibody, ATP pyrophosphate-lyase 5 antibody

UniProt: O95622

Pathways: EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Thyroid Hormone Synthesis, cAMP Metabolic Process, Myometrial Relaxation and Contraction, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma